Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WOMBAT: Bipolar Androgen Therapy in nmCRPC with PSA Progression on Darolutamide
NCT06594926Phase 2Recruiting
- Sponsor
- ANZUP Cancer Trials Group
- Start
- Aug 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of testosterone enanthate in prostate cancer (PCa), sponsored by ANZUP Cancer Trials Group. Started Aug 2024; status: recruiting.
02
Drugs
testosterone enanthate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06594926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06594926.